The expenditure on prescribed medicines in France has shown a continuous decline from 2013 to 2023. This trend is evident as the healthcare expenditure dropped from 12.8 units in 2013 to 10.44 units in 2023, representing an average annual decrease rate of -2.22% over the last 5 years. Specific year-on-year variations highlight significant declines in 2020, 2021, and 2023. However, despite a slight increase in 2017 and 2022, the general downward trend persisted due to various underlying factors.
The forecast for the next five years suggests that this downward trend will continue with an estimated average annual decrease of -1.72% and an overall reduction of 8.31% by 2028. These projections indicate that by 2028, expenditure will further decline to 9.38 units.
Future Trends to Watch For:
• The impact of pharmaceutical innovation and new drug approvals on expenditure.
• Policy changes related to drug pricing and healthcare reforms.
• Trends in chronic disease management and preventive care strategies.
• Demographic changes and their effects on drug consumption patterns.
